reported a case of a 68-year-old with a history of lung carcinoid tumor who developed a suprasellar lesion, in which key mutations in PTCH1 and BCOR that have been previously implicated in both systemic neuroendocrine and primary pituitary tumors with potentially actionable therapeutic targets (17). The gene discussed is PTCH1; the disease is lung carcinoid tumor.